Cannara Biotech Inc. (TSX:LOVE)
Canada
· Delayed Price · Currency is CAD 1.840
-0.030 (-1.60%)
At close: Mar 9, 2026
Cannara Biotech Cash Flow Statement
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 - 2018 |
| Net Income | 11.81 | 13.08 | 6.44 | 6.95 | 2.31 | -1.53 | Upgrade
|
| Depreciation & Amortization | 6.71 | 6.68 | 6.35 | 4.94 | 3.92 | 2.87 | Upgrade
|
| Other Amortization | 0.22 | 0.18 | 0.29 | 0.26 | 0.18 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.42 | -0.42 | -2.03 | 0.13 | 0.05 | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.56 | - | Upgrade
|
| Stock-Based Compensation | 2.59 | 1.19 | 1.98 | 1.75 | 0.35 | 0.33 | Upgrade
|
| Other Operating Activities | 8.02 | 5.61 | 0.16 | -2.48 | -0.84 | -0.21 | Upgrade
|
| Change in Accounts Receivable | -2.25 | -1.04 | -2.43 | -2.05 | -5.68 | -2.82 | Upgrade
|
| Change in Inventory | -10.06 | -8.47 | -3.98 | -8.33 | -8.23 | -3.37 | Upgrade
|
| Change in Accounts Payable | 1.4 | 0.53 | 2.22 | 5.48 | 2.28 | 2.45 | Upgrade
|
| Change in Unearned Revenue | 0.18 | -0.07 | 0.06 | 0.16 | 0.12 | 0.19 | Upgrade
|
| Change in Other Net Operating Assets | 3.93 | 2.75 | 1.63 | -0.9 | 0.02 | -0.27 | Upgrade
|
| Operating Cash Flow | 22.14 | 20.01 | 10.68 | 5.91 | -6.08 | -2.09 | Upgrade
|
| Operating Cash Flow Growth | 40.71% | 87.34% | 80.72% | - | - | - | Upgrade
|
| Capital Expenditures | -9.76 | -6.36 | -7.47 | -9.88 | -15.47 | -31.07 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.16 | 0.16 | 2.12 | 0.19 | 0.06 | 0.22 | Upgrade
|
| Other Investing Activities | 0.27 | 0.25 | 0.16 | 0.21 | 0.06 | 0.03 | Upgrade
|
| Investing Cash Flow | -9.34 | -5.95 | -5.19 | -9.48 | -15.35 | -30.83 | Upgrade
|
| Short-Term Debt Issued | - | 0.5 | 5.7 | 3 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 61.88 | 10.7 | Upgrade
|
| Total Debt Issued | - | 0.5 | 5.7 | 3 | 61.88 | 10.7 | Upgrade
|
| Short-Term Debt Repaid | - | -0 | -2.44 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -3.08 | -2.22 | -2.24 | -34.3 | -0.62 | Upgrade
|
| Total Debt Repaid | -3.14 | -3.08 | -4.67 | -2.24 | -34.3 | -0.62 | Upgrade
|
| Net Debt Issued (Repaid) | -3.14 | -2.58 | 1.03 | 0.76 | 27.58 | 10.08 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.05 | 0.05 | 24.66 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.28 | -0.37 | - | - | Upgrade
|
| Other Financing Activities | -3.41 | -3.74 | -3.9 | -4.63 | -2.17 | -1.49 | Upgrade
|
| Financing Cash Flow | -6.55 | -6.32 | -3.14 | -4.19 | 25.46 | 33.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0.08 | -0.08 | 0.06 | Upgrade
|
| Net Cash Flow | 6.26 | 7.74 | 2.35 | -7.84 | 3.96 | 0.39 | Upgrade
|
| Free Cash Flow | 12.38 | 13.65 | 3.21 | -3.97 | -21.55 | -33.17 | Upgrade
|
| Free Cash Flow Growth | 26.05% | 324.86% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 11.03% | 12.74% | 3.93% | -6.93% | -60.11% | -194.86% | Upgrade
|
| Free Cash Flow Per Share | 0.13 | 0.15 | 0.04 | -0.04 | -0.24 | -0.43 | Upgrade
|
| Cash Interest Paid | 2.8 | 3.21 | 3.05 | 4.31 | 1.19 | 1.32 | Upgrade
|
| Levered Free Cash Flow | 7.32 | 10.1 | -7.43 | -11.46 | -23.81 | -33.71 | Upgrade
|
| Unlevered Free Cash Flow | 9.17 | 12.28 | -4.69 | -8.75 | -22.6 | -32.68 | Upgrade
|
| Change in Working Capital | -6.8 | -6.3 | -2.5 | -5.64 | -11.48 | -3.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.